128 related articles for article (PubMed ID: 37094449)
1. Shifting the selectivity of pyrido[2,3-d]pyrimidin-7(8H)-one inhibitors towards the salt-inducible kinase (SIK) subfamily.
Rak M; Tesch R; Berger LM; Shevchenko E; Raab M; Tjaden A; Zhubi R; Balourdas DI; Joerger AC; Poso A; Krämer A; Elson L; Lučić A; Kronenberger T; Hanke T; Strebhardt K; Sanhaji M; Knapp S
Eur J Med Chem; 2023 Jun; 254():115347. PubMed ID: 37094449
[TBL] [Abstract][Full Text] [Related]
2. Structure-Based Design of Selective Salt-Inducible Kinase Inhibitors.
Tesch R; Rak M; Raab M; Berger LM; Kronenberger T; Joerger AC; Berger BT; Abdi I; Hanke T; Poso A; Strebhardt K; Sanhaji M; Knapp S
J Med Chem; 2021 Jun; 64(12):8142-8160. PubMed ID: 34086472
[TBL] [Abstract][Full Text] [Related]
3. Optimization of Selectivity and Pharmacokinetic Properties of Salt-Inducible Kinase Inhibitors that Led to the Discovery of Pan-SIK Inhibitor GLPG3312.
Temal-Laib T; Peixoto C; Desroy N; De Lemos E; Bonnaterre F; Bienvenu N; Picolet O; Sartori E; Bucher D; López-Ramos M; Roca Magadán C; Laenen W; Flower T; Mollat P; Bugaud O; Touitou R; Pereira Fernandes A; Lavazais S; Monjardet A; Borgonovi M; Gosmini R; Brys R; Amantini D; De Vos S; Andrews M
J Med Chem; 2024 Jan; 67(1):380-401. PubMed ID: 38147525
[TBL] [Abstract][Full Text] [Related]
4. Salt-inducible kinases (SIK) inhibition reduces RANKL-induced osteoclastogenesis.
Lombardi MS; Gilliéron C; Berkelaar M; Gabay C
PLoS One; 2017; 12(10):e0185426. PubMed ID: 28973003
[TBL] [Abstract][Full Text] [Related]
5. The LKB1-salt-inducible kinase pathway functions as a key gluconeogenic suppressor in the liver.
Patel K; Foretz M; Marion A; Campbell DG; Gourlay R; Boudaba N; Tournier E; Titchenell P; Peggie M; Deak M; Wan M; Kaestner KH; Göransson O; Viollet B; Gray NS; Birnbaum MJ; Sutherland C; Sakamoto K
Nat Commun; 2014 Aug; 5():4535. PubMed ID: 25088745
[TBL] [Abstract][Full Text] [Related]
6. Salt-Inducible Kinases: Physiology, Regulation by cAMP, and Therapeutic Potential.
Wein MN; Foretz M; Fisher DE; Xavier RJ; Kronenberg HM
Trends Endocrinol Metab; 2018 Oct; 29(10):723-735. PubMed ID: 30150136
[TBL] [Abstract][Full Text] [Related]
7. 14-3-3 cooperates with LKB1 to regulate the activity and localization of QSK and SIK.
Al-Hakim AK; Göransson O; Deak M; Toth R; Campbell DG; Morrice NA; Prescott AR; Alessi DR
J Cell Sci; 2005 Dec; 118(Pt 23):5661-73. PubMed ID: 16306228
[TBL] [Abstract][Full Text] [Related]
8. Development of Selective Pyrido[2,3-
Rak M; Menge A; Tesch R; Berger LM; Balourdas DI; Shevchenko E; Krämer A; Elson L; Berger BT; Abdi I; Wahl LM; Poso A; Kaiser A; Hanke T; Kronenberger T; Joerger AC; Müller S; Knapp S
J Med Chem; 2024 Mar; 67(5):3813-3842. PubMed ID: 38422480
[TBL] [Abstract][Full Text] [Related]
9. Silencing the constitutive active transcription factor CREB by the LKB1-SIK signaling cascade.
Katoh Y; Takemori H; Lin XZ; Tamura M; Muraoka M; Satoh T; Tsuchiya Y; Min L; Doi J; Miyauchi A; Witters LA; Nakamura H; Okamoto M
FEBS J; 2006 Jun; 273(12):2730-48. PubMed ID: 16817901
[TBL] [Abstract][Full Text] [Related]
10. Development of Chemical Probes for Investigation of Salt-Inducible Kinase Function in Vivo.
Sundberg TB; Liang Y; Wu H; Choi HG; Kim ND; Sim T; Johannessen L; Petrone A; Khor B; Graham DB; Latorre IJ; Phillips AJ; Schreiber SL; Perez J; Shamji AF; Gray NS; Xavier RJ
ACS Chem Biol; 2016 Aug; 11(8):2105-11. PubMed ID: 27224444
[TBL] [Abstract][Full Text] [Related]
11. High-Throughput Implementation of the NanoBRET Target Engagement Intracellular Kinase Assay to Reveal Differential Compound Engagement by SIK2/3 Isoforms.
Jin HY; Tudor Y; Choi K; Shao Z; Sparling BA; McGivern JG; Symons A
SLAS Discov; 2020 Feb; 25(2):215-222. PubMed ID: 31849250
[TBL] [Abstract][Full Text] [Related]
12. Pyrido[2, 3-d]pyrimidin-7(8H)-ones as new selective orally bioavailable Threonine Tyrosine Kinase (TTK) inhibitors.
Huang M; Huang Y; Guo J; Yu L; Chang Y; Wang X; Luo J; Huang Y; Tu Z; Lu X; Xu Y; Zhang Z; Zhang Z; Ding K
Eur J Med Chem; 2021 Feb; 211():113023. PubMed ID: 33248853
[TBL] [Abstract][Full Text] [Related]
13. The structures of salt-inducible kinase 3 in complex with inhibitors reveal determinants for binding and selectivity.
Öster L; Castaldo M; de Vries E; Edfeldt F; Pemberton N; Gordon E; Cederblad L; Käck H
J Biol Chem; 2024 May; 300(5):107201. PubMed ID: 38508313
[TBL] [Abstract][Full Text] [Related]
14. Identification of highly selective SIK1/2 inhibitors that modulate innate immune activation and suppress intestinal inflammation.
Babbe H; Sundberg TB; Tichenor M; Seierstad M; Bacani G; Berstler J; Chai W; Chang L; Chung M; Coe K; Collins B; Finley M; Guletsky A; Lemke CT; Mak PA; Mathur A; Mercado-Marin EV; Metkar S; Raymond DD; Rives ML; Rizzolio M; Shaffer PL; Smith R; Smith J; Steele R; Steffens H; Suarez J; Tian G; Majewski N; Volak LP; Wei J; Desai PT; Ong LL; Koudriakova T; Goldberg SD; Hirst G; Kaushik VK; Ort T; Seth N; Graham DB; Plevy S; Venable JD; Xavier RJ; Towne JE
Proc Natl Acad Sci U S A; 2024 Jan; 121(1):e2307086120. PubMed ID: 38147543
[TBL] [Abstract][Full Text] [Related]
15. Salt-inducible kinase regulates hepatic lipogenesis by controlling SREBP-1c phosphorylation.
Yoon YS; Seo WY; Lee MW; Kim ST; Koo SH
J Biol Chem; 2009 Apr; 284(16):10446-52. PubMed ID: 19244231
[TBL] [Abstract][Full Text] [Related]
16. The Triad Na
Gonsalez SR; Gomes DS; de Souza AM; Ferrão FM; Vallotton Z; Gogulamudi VR; Lowe J; Casarini DE; Prieto MC; Lara LS
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175599
[TBL] [Abstract][Full Text] [Related]
17. A parathyroid hormone/salt-inducible kinase signaling axis controls renal vitamin D activation and organismal calcium homeostasis.
Yoon SH; Meyer MB; Arevalo C; Tekguc M; Zhang C; Wang JS; Castro Andrade CD; Strauss K; Sato T; Benkusky NA; Lee SM; Berdeaux R; Foretz M; Sundberg TB; Xavier RJ; Adelmann CH; Brooks DJ; Anselmo A; Sadreyev RI; Rosales IA; Fisher DE; Gupta N; Morizane R; Greka A; Pike JW; Mannstadt M; Wein MN
J Clin Invest; 2023 May; 133(9):. PubMed ID: 36862513
[TBL] [Abstract][Full Text] [Related]
18. The Small-Molecule Inhibitor MRIA9 Reveals Novel Insights into the Cell Cycle Roles of SIK2 in Ovarian Cancer Cells.
Raab M; Rak M; Tesch R; Gasimli K; Becker S; Knapp S; Strebhardt K; Sanhaji M
Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359562
[TBL] [Abstract][Full Text] [Related]
19. AMPKα-like proteins as LKB1 downstream targets in cell physiology and cancer.
Molina E; Hong L; Chefetz I
J Mol Med (Berl); 2021 May; 99(5):651-662. PubMed ID: 33661342
[TBL] [Abstract][Full Text] [Related]
20. Salt-inducible kinase (SIK) isoforms: their involvement in steroidogenesis and adipogenesis.
Katoh Y; Takemori H; Horike N; Doi J; Muraoka M; Min L; Okamoto M
Mol Cell Endocrinol; 2004 Mar; 217(1-2):109-12. PubMed ID: 15134808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
